46 J. Chem. Inf. Model., Vol. 50, No. 1, 2010 slide or printed page, as well as developing interactive user interfaces for arranging and querying content data. The hierarchical atom-to-atom mapping system developed in this work has been used primarily for depiction purposes, but the assignment can also be used to differentiate scaffolds vs substituents at any level within the hierarchy, which opens up possibilities for fragment-based QSAR and clustering studies. REFERENCES AND NOTES (1) (a) Agraﬁotis, D. K.; Shemanarev, M.; Connolly, P. J.; Farnum, M.; Lobanov, V. S. SAR Maps: A New SAR Visualization Technique for Medicinal Chemists. J. Med. Chem. 2007, 50, 5926–5937. (b) Guha, R.; Van Drie, J. H. Structure-Activity Landscape Index: Identifying and Quantifying Activity Cliffs. J. Chem. Inf. Model. 2008, 48, 646– 658. (c) Guha, R.; Van Drie, J. H. Assessing How Well a Modeling Protocol Captures a Structure-Activity Landscape. J. Chem. Inf. Model. 2008, 48, 1716–1728. (d) Lounkine, E.; Auer, J.; Bajorath, J. Formal Concept Analysis for the Identiﬁcation of Molecular Fragment Combinations Speciﬁc for Active and Highly Potent Compounds. J. Med. Chem. 2008, 51, 5342–5348. (e) Wawer, M.; Peltason, L.; Weskamp, N.; Teckentrup, A.; Bajorath, J. Structure-Activity Rela- tionship Anatomy by Network-like Similarity Graphs and Local Structure-Activity Relationship Indices. J. Med. Chem. 2008, 51, 6075–6084. (f) Kolpak, J.; Connolly, P. J.; Lobanov, V. S.; Agraﬁotis, D. K. Enhanced SAR Maps: Expanding the Data Rendering Capabili- ties of a Popular Medicinal Chemistry Tool. J. Chem. Inf. Model. 2009, 49, 2221–2230. (2) (a) Bemis, G. W.; Murcko, M. A. The Properties of Known Drugs. 1. Molecular Frameworks. J. Med. Chem. 1996, 39, 2887–2893. (b) Wilkens, S. J.; Janes, J.; Su, A. I. HierS: Hierarchical Scaffold Clustering Using Topological Chemical Graphs. J. Med. Chem. 2005, 48, 3182–3193. (c) Shelat, A. A.; Guy, R. K. Scaffold composition and biological relevance of screening libraries. Nat. Chem. Biol. 2007, 3, 442–446. (d) Lounkine, E.; Bajorath, J. Core Trees and Consensus Fragment Sequences for Molecular Representation and Similarity Analysis. J. Chem. Inf. Model. 2008, 48, 1161–1166. (3) Schuffenhauer, A.; Ertl, P.; Roggo, S.; Wetzel, S.; Koch, M. A.; Waldmann, H. The Scaffold TreesVisualization of the Scaffold Universe by Hierarchical Scaffold Classiﬁcation. J. Chem. Inf. Model. 2007, 47, 47–58. (4) Weininger, D. SMILES 1. Introduction and Encoding Rules. J. Chem. Inf. Comput. Sci. 1988, 28, 31–36. CLARK (5) Labute, P. Protonate3D: Assignment of ionization states and hydrogen coordinates to macromolecular structures. Proteins: Struct. Funct. Bioinf. 2009, 75, 187–205. (6) Clark, A. M.; Labute, P. Detection and Assignment of Common Scaffolds in Project Databases of Lead Molecules. J. Med. Chem. 2009, 52, 469–483. (7) (a) Clark, A. M.; Labute, P.; Santavy, M. 2D Structure Depiction. J. Chem. Inf. Model. 2006, 46, 1107–1123. (b) Clark, A. M.; Labute, P. 2D Depiction of Protein-Ligand Complexes. J. Chem. Inf. Model. 2007, 47, 1933–1944. (8) A suitable grid spacing is 1 Å, assuming that the depiction layout is scaled such that the average bond distance is approximately 1.5 Å. (9) (a) Sutherland, J. J.; O’Brien, L. A.; Weaver, D. F. A Comparison of Methods for Modeling Quantitative Structure-Activity Relationships. J. Med. Chem. 2004, 47, 5541–5554. (b) Broughton, M. C.; Queener, S. F. Pneumocystis carinii Dihydrofolate Reductaste Used To Screen Potential Antipneumocystis Drugs. Antimicrob. Agents Chemother. 1991, 35, 1348–1355. (c) Rosowsky, A.; Hynes, J. B.; Queener, S. F. Structure-Activity and Structure-Selectivity Studies on Diamino- quinazolines and Other Inhibitors of Pneumocystis carinii and Toxo- plasma gondii Dihydrofolate Reductase. Antimicrob. Agents Chemoth- er. 1995, 39, 79–86. (d) Gangjee, A.; Elzein, E.; Queener, F.; McGuire, J. J. Synthesis and Biological Activities of Tricyclic Conformationally Restricted Tetrahydropyrido Annulated Furo[2,3-d]pyrimidines as Inhibitors of Dihydrofolate Reductases. J. Med. Chem. 1998, 41, 1409– 1416. (e) Nelson, R. G.; Rosowsky, A. Dicyclic and Tricyclic Diaminopyrimidine Derivatives as Potent Inhibitors of Cryptospo- ridium parVum Dihydrofolate Reductase: Structure-Activity and Structure-Selectivity Correlations. Antimicrob. Agents Chemother. 2001, 45, 3293–3303. (10) Agraﬁotis, D. K.; Bandyopadhyay, D.; Farnum, M. Radial Cluster- grams: Visualizing the Aggregate Properties of Hierarchical Clusters. J. Chem. Inf. Model. 2007, 47, 69–79. (11) (a) Williams, C. Reverse ﬁngerprinting, similarity searching by group fusion and ﬁngerprint bit importance. Mol. DiVersity 2006, 10, 311– 332. (b) Any common molecular ﬁngerprint scheme which distin- guishes between pharmacologically relevant features may be used instead. (12) The source code for the algorithms described within, and those referred to, is packaged as part of MOE and may be examined and used under the terms of the MOE user license, which is available from the Chemical Computing Group, Inc., 1010 Sherbrooke Street West, Suite 910, Montre´al, Que´bec, Canada. http://www.chemcomp.com (accessed 1 June, 2009). CI900350H